Home >> Research Area >>Natural Products>>Iridoids>> 8-O-Acetylharpagide

8-O-Acetylharpagide

CAS# 6926-14-3

8-O-Acetylharpagide

Catalog No. BCN4256----Order now to get a substantial discount!

Product Name & Size Price Stock
8-O-Acetylharpagide: 5mg $35 In Stock
8-O-Acetylharpagide: 10mg Please Inquire In Stock
8-O-Acetylharpagide: 20mg Please Inquire Please Inquire
8-O-Acetylharpagide: 50mg Please Inquire Please Inquire
8-O-Acetylharpagide: 100mg Please Inquire Please Inquire
8-O-Acetylharpagide: 200mg Please Inquire Please Inquire
8-O-Acetylharpagide: 500mg Please Inquire Please Inquire
8-O-Acetylharpagide: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of 8-O-Acetylharpagide

Number of papers citing our products

Chemical structure

8-O-Acetylharpagide

3D structure

Chemical Properties of 8-O-Acetylharpagide

Cas No. 6926-14-3 SDF Download SDF
PubChem ID 5459146 Appearance Powder
Formula C17H26O11 M.Wt 406.4
Type of Compound Iridoids Storage Desiccate at -20°C
Synonyms Harpagide 8-acetate
Solubility Soluble in DMSO and methanol; insoluble in water
Chemical Name [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] acetate
SMILES CC(=O)OC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)C
Standard InChIKey CAFTUQNGDROXEZ-CDZVNVNZSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of 8-O-Acetylharpagide

1 Caryopteris sp. 2 Lagochilus sp. 3 Scrophularia sp. 4 Stachys sp. 5 Teucrium sp.

Biological Activity of 8-O-Acetylharpagide

Description8-O-Acetylharpagide has anti-inflammatory, vasoconstrictor, antibacteria and antiviral activities, it also has a biological activity on isolated smooth muscle preparations from guinea pig. 8-O-Acetylharpagide presents the obvious inhibition on Epstein-Barr virus(EBV) infection, it not only apparently inhibits EBV-VCA,but also alleviates the hyperfunction and effusion of capillary permeability at the early inflammation.
TargetsAntifection
In vitro

Vasoconstrictor activity of 8-O-acetylharpagide from Ajuga reptans.[Pubmed: 1431938]

J Nat Prod. 1992 Aug;55(8):1145-8.

The traditional therapeutic indications for the use of Ajuga reptans (Labiatae) have been investigated. The H2O-soluble part of a crude and partially purified MeOH extract and two isolated iridoids (8-O-Acetylharpagide and harpagide), were tested for a biological activity on isolated smooth muscle preparations from guinea pig.

8-O-acetylharpagide is not an ecdysteroid agonist.[Pubmed: 11520686]

Insect Biochem Mol Biol. 2001 Oct;31(11):1077-82.


METHODS AND RESULTS:
We have reinvestigated the activity of 8-O-Acetylharpagide, an iridoid glucoside, as an ecdysteroid agonist. Elbrecht et al. (Insect Biochem. Mol. Biol. 26 (1996) 519) isolated a preparation of this compound from Ajuga reptans L. and ascribed ecdysteroid agonist activity on the basis of the induction of an ecdysteroid-like response in Drosophila melanogaster KcO cells, the displacement of [3H]ponasterone A from the Drosophila receptor and the activation of an ecdysteroid-regulated gene in a transactivation assay. We provide evidence that the agonist activity derives from contaminating ecdysteroids; A. reptans is a species rich in ecdysteroids.
CONCLUSIONS:
Purified 8-O-Acetylharpagide is not active in the D. melanogaster B(II) cell bioassay, neither as an agonist nor as an antagonist, nor does it displace [3H]ponasterone A from dipteran or lepidopteran ecdysteroid receptor complexes.

In vivo

Pharmacokinetics of 8-O-acetylharpagide and harpagide after oral administration of Ajuga decumbens extract in beagle dog.[Pubmed: 24066603]

Zhongguo Zhong Yao Za Zhi. 2013 Jun;38(12):2015-8.

8-O-Acetylharpagide and harpagide are two kinds of effective component of Ajuga decumbens extract. A sensitive LC-MS/MS method has been established for pharmacokinetics of 8-O-Acetylharpagide and harpagide in beagle dog after oral administration of from A. decumbens extract.
METHODS AND RESULTS:
Female beagle dogs received orally 12.9, 25.7 mg x kg(-1) p. o. Concentrations of 8-O-Acetylharpagide and harpagide in plasma were determined by LC-MS/MS method at different time points and all pharmacokinetic parameters were estimated by non-compartment analysis. The mobile phase consisted of 0.1% formic acid in water (A) and acetonitrile (B), which was run at a flow rate of 0.3 mL x min(-1). Chromatographic separation was achieved on an Agilent ZORBAX XDB-C18 column (2.1 mm x 50 mm, 3.5 microm) using a gradient elution of 5% B at 0-2 min, 95% B at 2. 1-5 min and 5% B at 5. 1-10 min. All analytes, including the IS, were monitored under positive ionization conditions and quantified in MRM mode with transitions of m/z 429.2-369.2 for 8-O-Acetylharpagide, m/z 387.2-207.2 for harpagide, and m/z 149.2-103.1 for IS. High purity nitrogen was employed as both the nebulizing and drying gas. Other parameters of the mass spectrometer were optimized as follows: drying gas flow 10.0 L x min(-1); drying gas temperature 300 degrees C; capillary voltage 4 000 V. Results showed that 8-O-Acetylharpagide and harpagide showed a dose-dependence profile. T(max) of 8-O-Acetylharpagide is 1.7 h, and T(max) of harpagide is 1.57 h, which was higher than T(max) of 8-O-Acetylharpagide and harpagide after oral administration of from A. decumbens extract in rats.
CONCLUSIONS:
The different pharmacokinetic parameters may be due to the species differences of rat and beagle dog.

Protocol of 8-O-Acetylharpagide

Animal Research

In Vivo and In Vitro Pharmacodynamics Study of 8-O-Acetylharpagide in the Prevention and Treatment of EB Viral Infection.[Reference: WebLink]

World Journal of Integrated Traditional & Western Medicine, 2013, 8(4):351-4.

To assess the pharmacodynamic effects of 8-O-Acetylharpagide in the prevention and treatment of Epstein-Barr virus(EBV)by in vivo and in vitro trial.
METHODS AND RESULTS:
The real-time fluorescent quantitative PCR(Real-time RT-PCR)technology was used to observe the inhibition of 8-O-Acetylharpagide on EBV viral capsid antigen(VCA)in B95-8 cell.By the intraperitoneal injection of acetic acid,the model of the increased celiac capillary permeability was prepared in mice for the detection of the inhibition of 8-O-Acetylharpagide on the hyperfunction and effusion of capillary permeability at the early inflammation. In the high-dose,middle-dose and low-dose groups,8-O-Acetylharpagide presented obvious inhibition on EBV-VCA in B95-8 separately(P0.01).In the high-dose and middle-dose groups,8-O-Acetylharpagide inhibited significantly the increased celiac capillary permeability in the mice induced by acetic acid(P0.01).
CONCLUSIONS:
8-O-Acetylharpagide presents the obvious inhibition on EBV infection.It not only apparently inhibits EBV-VCA,but also alleviates the hyperfunction and effusion of capillary permeability at the early inflammation.

8-O-Acetylharpagide Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

8-O-Acetylharpagide Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 8-O-Acetylharpagide

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.4606 mL 12.3031 mL 24.6063 mL 49.2126 mL 61.5157 mL
5 mM 0.4921 mL 2.4606 mL 4.9213 mL 9.8425 mL 12.3031 mL
10 mM 0.2461 mL 1.2303 mL 2.4606 mL 4.9213 mL 6.1516 mL
50 mM 0.0492 mL 0.2461 mL 0.4921 mL 0.9843 mL 1.2303 mL
100 mM 0.0246 mL 0.123 mL 0.2461 mL 0.4921 mL 0.6152 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 8-O-Acetylharpagide

Pharmacokinetics of 8-O-acetylharpagide and harpagide after oral administration of Ajuga decumbens Thunb extract in rats.[Pubmed:23545457]

J Ethnopharmacol. 2013 May 20;147(2):503-8.

ETHNOPHARMACOLOGICAL RELEVANCE: Ajuga decumbens Thunb is a medicinal plant native to China popularly used to treat chronic pelvic inflammation and hysteromyoma. Its main bioactive components are iridoid glycosides, such as 8-O-Acetylharpagide and harpagide that had presented antibacterial, anti-inflammatory, and antiviral activities. AIM OF THE STUDY: To establish a sensitive LC-MS/MS method and compare the pharmacokinetics of 8-O-Acetylharpagide and harpagide in rats after oral administration of their pure forms and from compounds obtained from Ajuga decumbens extract. MATERIALS AND METHODS: Rats received orally 15 mg/kg (equivalent of 6 mg/kg 8-O-Acetylharpagide and 1.5mg/kg harpagide), 30 mg/kg and 60 mg/kg of Ajuga decumbens Thunb extract and were compared to animals that received 12 mg/kg of 8-O-Acetylharpagide or 3mg/kg of harpagide p.o. Concentrations of 8-O-Acetylharpagide and harpagide in plasma were determined by LC-MS/MS method at different time points and all pharmacokinetic parameters were estimated by non-compartmental analysis. RESULTS: Results showed that the iridoid glycosides were quickly absorbed by oral route and showed a dose-dependence profile. Pharmacokinetic parameters of both glycosides were essentially the same except Tmax when dosed as the extract or pure forms. CONCLUSION: 8-O-Acetylharpagide was metabolized to harpagide, which affected the pharmacokinetic profiles of harpagide when dosed as the extract. This pharmacokinetic study seems to be useful for a further clinical study of Ajuga decumbens Thunb extract.

Vasoconstrictor activity of 8-O-acetylharpagide from Ajuga reptans.[Pubmed:1431938]

J Nat Prod. 1992 Aug;55(8):1145-8.

The traditional therapeutic indications for the use of Ajuga reptans (Labiatae) have been investigated. The H2O-soluble part of a crude and partially purified MeOH extract and two isolated iridoids (8-O-Acetylharpagide and harpagide), were tested for a biological activity on isolated smooth muscle preparations from guinea pig.

[Pharmacokinetics of 8-O-acetylharpagide and harpagide after oral administration of Ajuga decumbens extract in beagle dog].[Pubmed:24066603]

Zhongguo Zhong Yao Za Zhi. 2013 Jun;38(12):2015-8.

8-O-Acetylharpagide and harpagide are two kinds of effective component of Ajuga decumbens extract. A sensitive LC-MS/MS method has been established for pharmacokinetics of 8-O-Acetylharpagide and harpagide in beagle dog after oral administration of from A. decumbens extract. Female beagle dogs received orally 12.9, 25.7 mg x kg(-1) p. o. Concentrations of 8-O-Acetylharpagide and harpagide in plasma were determined by LC-MS/MS method at different time points and all pharmacokinetic parameters were estimated by non-compartment analysis. The mobile phase consisted of 0.1% formic acid in water (A) and acetonitrile (B), which was run at a flow rate of 0.3 mL x min(-1). Chromatographic separation was achieved on an Agilent ZORBAX XDB-C18 column (2.1 mm x 50 mm, 3.5 microm) using a gradient elution of 5% B at 0-2 min, 95% B at 2. 1-5 min and 5% B at 5. 1-10 min. All analytes, including the IS, were monitored under positive ionization conditions and quantified in MRM mode with transitions of m/z 429.2-369.2 for 8-O-Acetylharpagide, m/z 387.2-207.2 for harpagide, and m/z 149.2-103.1 for IS. High purity nitrogen was employed as both the nebulizing and drying gas. Other parameters of the mass spectrometer were optimized as follows: drying gas flow 10.0 L x min(-1); drying gas temperature 300 degrees C; capillary voltage 4 000 V. Results showed that 8-O-Acetylharpagide and harpagide showed a dose-dependence profile. T(max) of 8-O-Acetylharpagide is 1.7 h, and T(max) of harpagide is 1.57 h, which was higher than T(max) of 8-O-Acetylharpagide and harpagide after oral administration of from A. decumbens extract in rats. The different pharmacokinetic parameters may be due to the species differences of rat and beagle dog.

8-O-acetylharpagide is not an ecdysteroid agonist.[Pubmed:11520686]

Insect Biochem Mol Biol. 2001 Oct;31(11):1077-82.

We have reinvestigated the activity of 8-O-Acetylharpagide, an iridoid glucoside, as an ecdysteroid agonist. Elbrecht et al. (Insect Biochem. Mol. Biol. 26 (1996) 519) isolated a preparation of this compound from Ajuga reptans L. and ascribed ecdysteroid agonist activity on the basis of the induction of an ecdysteroid-like response in Drosophila melanogaster KcO cells, the displacement of [3H]ponasterone A from the Drosophila receptor and the activation of an ecdysteroid-regulated gene in a transactivation assay. We provide evidence that the agonist activity derives from contaminating ecdysteroids; A. reptans is a species rich in ecdysteroids. Purified 8-O-Acetylharpagide is not active in the D. melanogaster B(II) cell bioassay, neither as an agonist nor as an antagonist, nor does it displace [3H]ponasterone A from dipteran or lepidopteran ecdysteroid receptor complexes.

Description

8-O-Acetylharpagide is an iridoid isolated from Ajuga reptans with antitumoral, antiviral, antibacterial, and anti-inflammatory activities. 8-O-Acetylharpagide also has a biological activity on isolated smooth muscle preparations from guinea pig.

Keywords:

8-O-Acetylharpagide,6926-14-3,Harpagide 8-acetate,Natural Products, buy 8-O-Acetylharpagide , 8-O-Acetylharpagide supplier , purchase 8-O-Acetylharpagide , 8-O-Acetylharpagide cost , 8-O-Acetylharpagide manufacturer , order 8-O-Acetylharpagide , high purity 8-O-Acetylharpagide

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: